EGFR and neoplasm: The reasons may include potential antagonism between platinum drugs and EGFR-TKIs[9] or that cell cycle-specific chemotherapy drugs are difficult to play a role because EGFR-TKIs arrest the tumor cell cycle at G1 phase[10].